The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MYTX-011, a cMET-targeting antibody-drug conjugate (ADC), in patients with previously treated, advanced NSCLC: Updated dose escalation results in the phase 1 KisMET-01 study.
 
Rebecca Heist
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Biohaven Pharmaceuticals; Claim Therapeutics; Daichii Sankyo; Daichii Sankyo; Genentech/Roche; Gilead Sciences; Lilly; Merck; Novartis; Regeneron; Sanofi
Research Funding - Abbvie (Inst); Agios (Inst); Corvus Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Erasca, Inc (Inst); Exelixis (Inst); Exelixis (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Modex (Inst); Mythic Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Roche (Inst); Turning Point Therapeutics (Inst)
 
Elaine Shum
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb/Roche; Genentech; Gilead Sciences; Janssen; Regeneron
Research Funding - Delfi Diagnostics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Janssen
 
Ester Garcia
No Relationships to Disclose
 
Malinda Itchins
Honoraria - AstraZeneca; MSD Oncology; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Gilead Sciences; Janssen Oncology; Medison; MSD Oncology; Pfizer; Roche
Research Funding - Pfizer (Inst)
 
Bo Gao
Consulting or Advisory Role - BeiGene; IMPAC Medical Systems; IMPAC Medical Systems; MSD
 
Ji-Youn Han
Honoraria - AstraZeneca; Janssen; Merck; Novartis; Pfizer; Takeda; Yuhan
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Daiichi Sankyo/UCB Japan; Janssen; Lantern Pharma; Merck; Novartis; Oncovix; Takeda
Research Funding - Pfizer; Roche
 
George Blumenschein
Employment - Janssen (I); johnon & Johnson (I)
Stock and Other Ownership Interests - Virogin Biotech
Consulting or Advisory Role - Abbvie; Adicet Bio; Amgen; ARIAD; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Celgene; Clovis Oncology; CytomX Therapeutics; Daiichi Sankyo, INC; Genentech; Genzyme; Gilead Sciences; Immunocore; Instil Bio; InterVenn Biosciences; Janssen Oncology; Johnson & Johnson (I); Lilly; Maverick Therapeutics; MedImmune; Merck; Novartis; Onconova Therapeutics; Regeneron; Roche; Sanofi; Scorpion Therapeutics; Seagen; Tyme; Virogin Biotech; Xcovery
Research Funding - Adaptimmune; Amgen; AstraZeneca; Aulos Bioscience; Bayer; BeiGene; Bristol-Myers Squibb; Celgene; CytomX Therapeutics; Daiichi Sankyo INC; Duality Biologics; Exelixis; Genentech; GlaxoSmithKline; Immatics; Immunocore; Incyte; Kite, a Gilead company; Macrogenics; MedImmune; Medimmune; Merck; Merck; Mythic Therapeutics; Novartis; Nuvalent, Inc.; Regeneron; Repertoire Immune Medicines; Roche; Sanofi; seagen; Takeda; Tmunity Therapeutics, Inc.; Torque; Turning Point Therapeutics; Verastem; Xcovery
 
Sarah Benafif
No Relationships to Disclose
 
Mariam Alexander
Consulting or Advisory Role - Abbvie; Amgen; Bayer; Janssen Oncology
Speakers' Bureau - IDEOlogy Health
 
Rohit Joshi
Honoraria - Bristol-Myers Squibb; Gilead Sciences; Ipsen; Merck Sharp & Dohme; Pfizer; Pfizer/EMD Serono; Roche
Consulting or Advisory Role - AstraZeneca; Merck Sharp & Dohme; Roche
Speakers' Bureau - Gilead Sciences
Travel, Accommodations, Expenses - Novartis
 
Jih-hsiang Lee
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Johnson & Johnson/Janssen; Lilly; Merck; Novartis; Takeda
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Pfizer
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Ono Pharmaceutical
 
Nicholas Coupe
Honoraria - Bristol Myers Squibb Foundation; Pierre Fabre
Travel, Accommodations, Expenses - Pierre Fabre
 
Nicolas Girard
Employment - AstraZeneca (I)
Consulting or Advisory Role - Abbvie; AMGEN; AstraZeneca; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Ipsen; Janssen; LEO Pharma; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); BMS (Inst); MSDavenir (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Janssen Oncology; Roche
 
Brian Fiske
Employment - Mythic Therapeutics
Leadership - Mythic Therapeutics
Stock and Other Ownership Interests - Mythic Therapeutics
Patents, Royalties, Other Intellectual Property - Inventor on patents related to MYTX-011, Mythic's other pipeline programs, and platform technology
 
Malina Traianova
No Relationships to Disclose
 
William Downing
Employment - Mersana; Mythic Therapeutics
Travel, Accommodations, Expenses - Mersana; Mythic Therapeutics
 
Thao Nguyen
Employment - Ipsen; Mythic Therapeutics; Mythic Therapeutics
Stock and Other Ownership Interests - Mythic Therapeutics
Travel, Accommodations, Expenses - Ipsen; Mythic Therapeutics
 
Ting-Hui Wu
Employment - AstraZeneca (I); Mythic Therapeutics; Novartis Institutes for BioMedical Research (I); Omega Therapeutics
Stock and Other Ownership Interests - AstraZeneca (I); Mythic Therapeutics; Novartis (I); Omega Therapeutics
 
Gilles Gallant
Employment - Daiichi Sankyo; Mythic Therapeutics
Leadership - Mythic Therapeutics
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Alcon; Amgen; BioMarin; Bristol-Myers Squibb; Johnson & Johnson/Janssen; Merck; Merck; Novartis; Pfizer; Sandoz
Consulting or Advisory Role - Repare Therapeutics
 
Hye Ryun Kim
Honoraria - AstraZeneca; MSD Oncology
Consulting or Advisory Role - AstraZeneca; BeiGene
Speakers' Bureau - ABL Bio; AstraZeneca; MSD Oncology; Ono Pharmaceutical; Roche/Genentech; Yuhan
Research Funding - AstraZeneca (Inst); Yuhan (Inst)